IM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 299 Washington St,
- Phone
- 781-235-3060
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- imtherapeutics.com
- Keywords
- The Lillylulu Foundation.
- HQ
- Woburn, Massachusetts
Im Therapeutics Questions
Im Therapeutics's helpline number is 781-235-3060
Im Therapeutics's website is imtherapeutics.com
Im Therapeutics's LinkedIn profile is https://www.linkedin.com/company/im-therapeutics
Im Therapeutics has
5 employees.
View email and phone details for 5
employees at Im Therapeutics.
Im Therapeutics's industry is
Biotechnology Research
Im Therapeutics's top competitors are
Thermalin Inc.,
Blue Gen Therapeutics Foundation,
T1d Action,
Creagen, Inc.,
C2i Accelerator,
Fekra Therapeutics,
Labgarden,
The Lillylulu Foundation,
Stelexis Biosciences, Inc.,
Revolo Biotherapeutics.
Im Therapeutics's support email address is info@imtherapeutics.com
Im Therapeutics's categories are Biotechnology Research
Im Therapeutics's founding year is 2015
